GANGLIONEUROBLASTOMA, NODULAR
Clinical trials for GANGLIONEUROBLASTOMA, NODULAR explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROBLASTOMA, NODULAR trials appear
Sign up with your email to follow new studies for GANGLIONEUROBLASTOMA, NODULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for kids with rare cancer: new combo therapy shows promise
Disease control Recruiting nowThis study tests whether adding the drug dinutuximab to standard chemotherapy and other treatments helps children with high-risk neuroblastoma live longer without their cancer returning. About 478 children and young adults up to age 30 will be randomly assigned to receive either …
Matched conditions: GANGLIONEUROBLASTOMA, NODULAR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Promising new combo therapy aims to improve survival in kids with aggressive nerve cancer
Disease control Recruiting nowThis study tests whether adding a radioactive drug (131I-MIBG) or a targeted pill (lorlatinib) to standard intensive therapy helps children and young adults with newly diagnosed high-risk neuroblastoma live longer without the cancer returning. About 750 participants aged 1 to 30 …
Matched conditions: GANGLIONEUROBLASTOMA, NODULAR
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC